BARCLAYS PLC

Position in CLLS — Cellectis S.A.

CIK 312069 LONDON, X0

Position in CLLS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$710

+$666 QoQ

Shares Held

224

+700.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. CLLS ranks #354 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	663,263	$296,173,457
2	REGN	Regeneron Pharmaceuticals, Inc.	313,093	$241,908,173
3	ALNY	Alnylam Pharmaceuticals, Inc.	220,623	$72,997,531
4	MRNA	Moderna, Inc.	932,269	$47,359,264
5	INSM	INSMED Inc	275,731	$45,087,531
6	ROIV	Roivant Sciences Ltd.	1,415,848	$39,218,988
7	RVMD	Revolution Medicines, Inc.	383,179	$37,264,156
8	TERN	Terns Pharmaceuticals, Inc.	669,601	$35,301,364

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$710	224	+700.0%	Shares	Defined	2026-05-15
2023-09-30	$44	28	0.0%	Shares	Sole	2026-03-26
2023-06-30	$55	28	0.0%	Shares	Sole	2026-03-27
2023-03-31	$54	28	0.0%	Shares	Sole	2026-03-30
2022-12-31	$58	28	-95.7%	Shares	Sole	2026-03-30
2022-09-30	$1,488	650	-72.0%	Shares	Sole	2022-11-03
2021-12-31	$18,870	2,324	-94.7%	Shares	Sole	2022-02-23
2021-09-30	$549,644	43,588	-31.2%	Shares	Sole	2021-11-09
2021-06-30	$980,627	63,389	+173.0%	Shares	Sole	2021-08-13
2021-03-31	$469,195	23,216	+412.7%	Shares	Sole	2021-05-13
2020-12-31	$122,527	4,528	+833.6%	Shares	Sole	2021-02-11
2020-09-30	$8,972	485	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.